Skip to main content

Table 1 The clinicopathological characteristics of studied patients

From: The role of protein inhibitor of activated STAT3 and miRNA-18a expressions in breast cancer

Variables

Patients

(n = 25)

(%)

Age (years)

 > 50

13

52

 ≤ 50

12

48

Focality

 Unifocal

23

92

 Multifocal

2

8

Tumor size

 < 2 cm

14

56

 ≥ 2 cm

11

44

Histopathological type

 IDC

20

80

 ILC

1

4

 DCIS

4

16

Pathological grade

 GI

4

16

 GII

15

60

 GIII

6

24

Lymphovascular invasion

 Negative

3

12

 Positive

22

88

LN metastasis

 No

12

48

 Yes

13

52

TNM stage

 IA

7

28

 IIA + IIB

13

52

 III

5

20

ER

 Positive

19

76

 Negative

6

24

PR

 Positive

19

76

 Negative

6

24

HER2

 Positive

20

80

 Negative

5

20

Molecular type

 Luminal A

5

20

 Luminal B

14

56

 HER2 enriched

6

24

  1. n number, LN lymph node, ER estrogen receptors, PR progesterone receptors, HER2 epidermal growth factor receptor 2, TNM tumor-node-metastasis classification system